[New results of endocrine therapy of breast cancer (the role of Aromasin)].
Semiglazov
V F
VF
Semiglazov
V V
VV
Klemtsel'
A A
AA
Barash
N Iu
NIu
Zhil'tsova
E K
EK
Bozhok
A A
AA
Mel'nikova
O A
OA
Paltuev
R M
RM
Dashian
G A
GA
Petrovskiĭ
S G
SG
Ivanov
V G
VG
Tonuzov
E E
EE
Berstein
L M
LM
D000730:Androstadienes / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D047072:Aromatase Inhibitors / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D013629:Tamoxifen / Q000627:therapeutic use; D016896:Treatment Outcome
D000730:Androstadienes; D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D013629:Tamoxifen; C056516:exemestane